Skip to main content
H

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 521 across all filing types
Latest filing 2026-04-26 Share Issue/Capital Cha…
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - HMD 6 pages 19.3KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX ‘Appendix 3G’ notification detailing the issue of unquoted equity securities (performance rights) under an employee incentive scheme. This is a direct announcement of new share/equity issuance. It does not fit executive management changes, dividends, or legal proceedings. It corresponds to a Share Issue/Capital Change filing.
2026-04-26 English
Notification regarding unquoted securities - HMD 7 pages 21.8KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3G notice detailing the issue of new unquoted equity securities (employee options) by Heramed Limited. This is an announcement of a share issuance/capital change event under ASX Listing Rules. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-04-26 English
Change of Director's Interest Notice TC DH SR 9 pages 361.3KB
Director's Dealing Classification · 1% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” showing detailed movements in securities held by multiple directors under ASX Listing Rule 3.19A. It records numbers of securities acquired/disposed, nature of interests, dates, and related trust details. This is a direct insider transaction report, matching the definition of Director’s Dealing. There is no indication that it is a publication announcement or any other category.
2026-04-26 English
Letter to Shareholders, Notice of AGM & Proxy Form 43 pages 1.8MB
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an ASX announcement dated 21 April 2026 providing the Notice of Annual General Meeting, Letter to Shareholders, Proxy Form and Explanatory Statement. It is not the company’s financial report but rather materials sent to shareholders to inform and solicit their votes in advance of the AGM. This corresponds to a Proxy Solicitation & Information Statement.
2026-04-20 English
Change of Director's Interest Notice - SR 2 pages 169.2KB
Regulatory Filings
2026-04-09 English
Notification regarding unquoted securities - HMD 6 pages 20.0KB
Regulatory Filings
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.